The peripheral differentiation of human natural killer T cells by Liu, Jie et al.
ORIGINAL ARTICLE OPEN
The peripheral differentiation of human natural killer T cells
Jie Liu1,2, Brenna J Hill3, Sam Darko3, Kaimei Song2, Maire F Quigley4, Tedi E Asher3, Yohei Morita5,
Hui Y Greenaway6, Vanessa Venturi6, Daniel C Douek3, Miles P Davenport6, David A Price3,4,a &
Mario Roederer2,a
1 Laboratory of Infectious Diseases and Vaccines, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041,
PR China
2 ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health,
Bethesda, MD 20892, USA
3 Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health,
Bethesda, MD 20892, USA
4 Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, UK
5 Leibniz Institute on Aging, Fritz Lipmann Institute, 07745 Jena, Germany
6 Infection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales Sydney, Sydney, NSW 2052, Australia
Keywords
NKT cell, T-cell differentiation, TCR, TREC
Correspondence
David A Price, Division of Infection and
Immunity, Cardiff University School of
Medicine, Heath Park, Cardiff CF14 4XN, UK.
E-mail: priced6@cardiff.ac.uk
and
Mario Roederer, ImmunoTechnology Section,
Vaccine Research Center, National Institute
of Allergy and Infectious Diseases,
National Institutes of Health, Bethesda,
MD 20892, USA.
E-mail: roederer@nih.gov
aEqual contributors.
Received 4 May 2017; Revised 7 June 2017,
27 June 2018, 27 January and 11 March
2019; Accepted 11 March 2019
doi: 10.1111/imcb.12248
Immunology & Cell Biology 2019; 1–11
Abstract
The peripheral maturation of human CD1d-restricted natural killer T (NKT)
cells has not been well described. In this study, we identified four major subsets
of NKT cells in adults, distinguished by the expression of CD4, CD8 and
CCR5. Phenotypic analysis suggested a hierarchical pattern of differentiation,
whereby immature CD4+CD8CCR5 cells progressed to an intermediate
CD4+CD8CCR5+ stage, which remained less differentiated than the
CD4CD8 and CD4CD8+ subsets, both of which expressed CCR5. This
interpretation was supported by functional data, including clonogenic potential
and cytokine secretion profiles, as well as T-cell receptor (TCR) excision circle
analysis. Moreover, conventional and high-throughput sequencing of the
corresponding TCR repertoires demonstrated significant clonotypic overlap
within individuals, especially between the more differentiated CD4CD8 and
CD4CD8+ subsets. Collectively, these results mapped a linear differentiation
pathway across the post-thymic landscape of human CD1d-restricted
NKT cells.
INTRODUCTION
Classical natural killer T (NKT) cells express a highly
biased T-cell receptor (TCR) repertoire and serve as a
bridge between the innate and adaptive immune
systems.1,2 The semi-invariant human NKT cell TCR
comprises a fixed TRAV10/TRAJ18 gene-encoded a-chain
with a canonical CDR3a loop3 and a restricted TRBV25
gene-encoded b-chain, which together enable the
recognition of glycolipids presented in the context of
CD1d.4 NKT cells deploy a range of effector functions in
response to antigen encounter and contribute in various
ways to the immune processes that mediate pathogen
control, tumor surveillance, allergic phenomena and
autoimmune disorders.5
Although initially considered to be homogeneous, later
studies revealed considerable phenotypic and functional
diversity within the peripheral NKT cell compartment.
Two subsets, CD4+CD8 and CD4CD8, have been
described in mice, and a third subset, CD4CD8+, has
1
Immunology & Cell Biology 2019; 1–11
www.wileyonlinelibrary.com/journal/icb
been described in humans.6 These patterns of coreceptor
use segregate with functionally distinct effector
programs.7,8 The development of murine NKT cells is
thought to comprise four stages, based on the expression
of CD24, CD44 and NK1.1.9,10 Further nuances are
suggested by the existence of mature
PLZFhighTbetlowRORctlow interleukin (IL)-4-producing
and PLZFhighTbetlowRORcthigh IL-17-producing subsets in
the thymus that resemble NK1.1 NKT cells.11,12 It is
also likely that peripheral CD4+ and CD4 NKT cells in
mice represent distinct lineages that emigrate
independently from the thymus.13 However, the extent to
which human NKT cells follow an equivalent
differentiation pathway remains unclear, despite close
parallels in the TCR-mediated antigen recognition process
and the highly conserved nature of CD1d.
In this study, we combined phenotypic, functional and
molecular techniques to characterize the post-thymic
differentiation of human NKT cells. Our data supported
the notion of a single lineage compartment and outlined
a maturation pathway compatible with the reported
heterogeneity among circulating subsets of CD1d-
restricted NKT cells.
RESULTS
Identification of NKT cells
Historically, NKT cells were identified by the expression
of TRAV10/TRBV25 heterodimeric TCRab
complexes.14,15 More recently, multimers of human CD1d
(hCD1d) incorporating one of two different glycolipids
(aGalCer or PBS57) have been used to detect NKT cells
on the basis of antigen specificity.16-18 As shown in
Figure 1a, a vast majority of CD3+ PBS57-hCD1d
multimer-binding cells expressed the invariant TCR.
Among total peripheral blood mononuclear cells
(PBMCs), only 0.08%  0.06 (n = 12) of multimer-
binding cells lacked CD3, thereby demonstrating both the
exquisite specificity and selectivity of this reagent. In
contrast, dual staining for TRAV10 (Va24) and TRBV25
(Vb11) revealed a small population of non-NKT cells
(3.5%  2.5; n = 12). We therefore used the PBS57-
hCD1d multimer to characterize NKT cells.
Phenotypic analysis of NKT cells
To define the properties of PBS57-hCD1d multimer-
binding cells, we initially measured several proteins
typically expressed by T and/or NK cells (Figure 1b and
Table 1). The NK cell markers CD56 and CD161 were
found at much higher frequencies on NKT cells
compared with conventional T cells. In contrast, NKT
cells almost completely lacked CD16 and infrequently
expressed the NK recognition molecules NKB1 and
NKAT2. These results largely concurred with a previous
report that used the monoclonal antibody 6B11 to
identify NKT cells.19 However, there were two notable
exceptions. First, we found that nearly all NKT cells
expressed CD95, consistent with a predominant memory
phenotype.20 Second, we found that a higher fraction of
NKT cells expressed CD56. These differences likely
reflected greater sensitivity in our flow cytometry panel
for these dimly expressed proteins.
Most NKT cells expressed CCR5 but lacked CD45RA
and CD62L, a phenotype reminiscent of effector T cells.
However, similarly high frequencies of NKT cells expressed
CD27, CD28 and CD127, markers typically associated with
central memory T cells. The expression of cytolytic enzymes
was also consistent with a central memory phenotype, in
that most NKT cells expressed granzyme A, whereas only a
few expressed granzyme B, and virtually none expressed
perforin. NKT cells therefore occupied a unique phenotypic
niche most akin to central memory T cells.
Subsets of NKT cells
Analysis of the T-cell lineage markers CD4 and CD8
confirmed that NKT cells could be divided into three
subsets: CD4+CD8 (CD4+), CD4CD8 (DN) and
CD4CD8+ (CD8+) (Figure 2a). Unlike conventional
CD8ab+ T cells, but allied to NK and cd T cells, NKT cells
expressed CD8 exclusively as the homodimer CD8aa.
Functional analysis of NKT cells
To determine the functional characteristics of NKT cells,
we stimulated PBMCs with aGalCer, anti-CD3 or PBS57-
hCD1d in the presence of brefeldin A and measured the
expression of intracellular cytokines, namely IL-2, IL-4,
TNF and IFNc. The PBS57-hCD1d multimer emerged as
the most potent stimulant (data not shown). In line with
the division-linked heterogeneity of memory T cells,
functional differences were evident among phenotypically
defined subsets of NKT cells (Figure 2b). In particular, we
found that CD4+ and DN NKT cells were significant
sources of IL-4, as reported previously.7,8,19,21-23 Large
fractions of CD4+ NKT cells also expressed high levels of
IL-2 and TNF compared with CD4 NKT cells. In
contrast, CD4 NKT cells more frequently expressed IFNc.
These patterns of cytokine secretion suggested that CD4+
NKT cells were less differentiated than CD4 NKT cells.
In further experiments, we sorted NKT cell subsets to
purity and quantified extracellular cytokine secretion in
response to stimulation with the PBS57-hCD1d multimer
(Figure 2c). These measurements were largely concordant
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with the intracellular cytokine profiles, barring a few
minor discrepancies likely attributable to methodological
differences. One notable exception was the finding that
DN NKT cells produced high levels of TNF, which
suggested greater output on a per cell basis relative to
CD4+ or CD8+ NKT cells.
Differentiation of NKT cells
On the basis of these functional traits, we hypothesized
that CD4+ NKT cells were less differentiated than CD4
NKT cells. This inference was substantiated by comparing
markers of differentiation across NKT cell subsets
(Table 2). Fewer CD4+ NKT cells expressed CD11a, CCR5,
granzymes A and B, and NK-associated markers compared
with CD4 NKT cells. In contrast, CD4+ NKT cells more
frequently expressed CD62L. Careful analysis further
revealed distinct subsets of CD4+ NKT cells. The smaller
population, representing about 5–10% of CD4+ NKT cells,
expressed CD62L but lacked CCR5, CD161 and granzyme
A (Figure 3a and Supplementary figure 1). This phenotype
was reminiscent of na€ıve T cells, with the exception that
NKT cells rarely expressed CD45RA. The CCR5 subset
therefore appeared to be less differentiated than the CCR5+
subset within the CD4+ NKT cell compartment.
To confirm these findings, we undertook several
independent lines of experimentation. First, we
characterized NKT cells in cord blood (Figure 3b). These
progenitors were found to be uniformly CD4+CCR5
(and still CD45RA), with a functional profile similar to
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Figure 1. Identification and phenotype of human NKT cells. (a) Viable CD3+ cells (left) were assessed for TRAV10 (Va24) and TRBV25 (Vb11)
expression (top right) or PBS57-hCD1d multimer binding (bottom right). Data are representative of three independent experiments (n = 5–12
subjects). PI, propidium iodide. (b) Expression of the indicated phenotypic markers is shown for NKT (PBS57-hCD1d+) and conventional T cells
(PBS57-hCD1d). Plots are gated on viable CD3+ cells. Data are representative of five independent experiments (n = 12 subjects). Summary
statistics are provided in Table 1.
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that of adult CD4+ NKT cells (high expression of TNF
and relatively low expression of IFNc). Second, we
quantified T-cell receptor excision circles (TRECs) in
NKT cell subsets. TREC levels decline geometrically with
the number of divisions since rearrangement of the
TCR.24 As shown in Figure 3c, the highest TREC levels
were detected in adult and cord blood CD4+CCR5 NKT
cells. This subset therefore emerged during the initial
stages of development. Progressively lower TREC levels
were present in CD4+CCR5+ and CD4 NKT cells. Third,
we cloned phenotypically defined NKT cells. In line with
previous studies of in vitro proliferation,25,26 we found
that CD4+ NKT cells were significantly more amenable to
clonogenic expansion compared with CD4 NKT cells
(Figure 3d). It was also notable that CD4 persisted on the
surface of all expanded CD4+ NKT cell clones (data not
shown). This finding suggested that any transition to the
CD4 state was either rare or contingent on additional
stimuli, such as further proliferation or an unknown
in vivo signal. Similarly, both DN and CD8+ NKT cells
largely retained their phenotypes in culture, although
there was some plasticity in the expression of CD8a.
Most CD8+ clones became heterogeneous in this respect,
and the occasional DN clone acquired CD8a.
Clonotypic analysis of NKT cell subsets
To probe these lineage relationships in more detail, we
performed an unbiased molecular analysis of all expressed
TR gene products in sort-purified (> 98%) subsets of
NKT cells. The flow cytometric sorting strategy is shown
in Supplementary figure 2.
In a cross-sectional analysis of three healthy subjects, we
found that the canonical TRAV10/CVVSDRGSTLGRLY/
TRAJ18 sequence14,15,27 was ubiquitous and highly
conserved at the nucleotide level among CD4+, DN and
CD8+ NKT cells (Figure 4a, b). Some additional TCRa
sequences were detected, especially in subject 4,
presumably reflecting a lack of allelic exclusion. In line
with previous reports,28 the corresponding TCRb
sequences were substantially more diverse and
predominantly TRBV25-1+ (Figure 4c, d). Importantly, we
found nucleotide-identical TCRb clonotypes within all
three phenotypically defined subsets from subject 4 and
subject 7, thereby providing direct evidence that CD4+,
DN and CD8+ NKT cells were related by ancestry and/or
interconversion. Our data were significant in this context.
Assuming a null hypothesis that each subset arose
independently, equivalent sharing of TCRb sequences
would have been expected among CD4+, DN and CD8+
NKT cells both within and between subjects. This scenario
was rejected (P < 104; Fisher’s exact test).
To confirm and extend these findings, we used high-
throughput sequencing to analyze TCRb sharing across
NKT cell subsets in three additional healthy subjects. In
each case, two samples of peripheral blood were taken
6 months apart, thereby enabling an assessment of
clonotype distribution over time. Moreover, the CD4+ NKT
cell subset was further sort-purified on the basis of CCR5
expression. In line with our conventional sequencing
analysis, we found shared clonotypes at individual time
points across all four phenotypically defined subsets of NKT
cells (Figure 5a). The most extensive overlap was detected
between DN and CD8+ NKT cells. This pattern was
recapitulated in the longitudinal dataset, suggesting a high
degree of fluidity between these phenotypes (Figure 5b).
Relatively few TCRb sequences were shared over time,
however, especially between the CD4+ and CD4 NKT cell
subsets. A few CD4+CCR5+ clonotypes nonetheless appeared
to seed the DN and CD8+ populations. In contrast, no
transitions were observed back to the CD4+CCR5 state.
Collectively, these data provided evidence for linear
differentiation within a highly dynamic system.
DISCUSSION
Human NKT cells were classified previously into three
broad subsets, defined on the basis of coreceptor
Table 1. NKT cell expression of surface markers.
Marker % of total T cells % of NKT cells
NK-associated markers
CD16 2.4  0.6 0.1  0.2
CD56 5.0  2.8 62.8  29.0
CD161 10.4  2.6 86.1  14.6
NKB1 1.7  0.6 4.6  3.3
NKAT2 2.4  2.1 0.2  0.1
Differentiation-associated markers
CD7 92.0  2.6 96.8  2.3
CD11ahigh 40.5  12.1 94.3  2.9
CD27 86.9  5.3 86.1  5.2
CD28 71.1  5.6 90.5  5.9
CD45RA 38.8  6.6 2.3  1.2
CD57 5.1  3.1 1.3  0.7
CD62L 76.0  2.8 7.5  1.4
CD95 57.3  7.3 92.0  3.2
CD127 46.7  1.2 76.2  6.1
CCR5 15.3  6.0 86.3  7.6
Cytolytic enzymes
Granzyme A 17.0  10.36 88.2  2.8
Granzyme B 6.1  4.5 15.0  4.6
Perforin 2.6  2.4 0.2  0.4
Lineage markers
CD4 68.7  10.1 15.2  9.0
CD8 22.1  8.7 19.5  6.6
Percentages are given as mean  one standard deviation for 5–
12 subjects.
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expression (CD4+, DN and CD8+). Earlier work also
suggested that NKT precursors expressed CD4 but not
CD161. This view was upheld by the observation that
CD4+ NKT cells predominated both in cord blood and in
the thymus.29-31 Moreover, the expression of CD161 was
shown to increase with age in young humans,30
consistent with a progressive maturation of the NKT cell
compartment. In line with previous studies,8,32,33 we
found that CD4+ NKT cells could be subdivided
according to the expression of CCR5. Our collated
phenotypic, functional and molecular data further
indicated that these subsets represented distinct stages of
maturation within the post-thymic NKT cell pool.
CD4+CCR5 NKT cells likely emerged first in the
periphery. These cells expressed many markers commonly
associated with a na€ıve phenotype among conventional T
cells (CD27, CD28, CD62L, CD127 and low CD11a) and
lacked cytolytic enzymes (granzymes A and B, and perforin).
They also harbored TREC levels comparable to those found
in cord blood NKT cells, which shared all of the same
phenotypes. This finding suggested that CD4+CCR5 NKT
cells were produced continuously throughout adulthood.
However, these cells were clearly not na€ıve in the classical
sense, because they did not express CD45RA and could be
triggered in some instances to produce IFNc.
CD4+CCR5+ NKT cells appeared to be more
differentiated. They had lower TREC levels, consistent with
an average of two additional divisions from the CCR5
stage, and readily produced effector cytokines upon
restimulation. During in vitro clonal expansion, however,
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Figure 2. Subsets of NKT cells. (a) Expression of CD4, CD8a and CD8b is shown for NKT (PBS57-hCD1d+) and conventional T cells (PBS57-
hCD1d) from a representative individual. Plots are gated on viable CD3+ cells. Quadrant numbers indicate percentage values. The percentages
are averaged across three independent experiments (n = 7 subjects). (b) Expression of the indicated cytokines is shown for CD4+, DN and CD8+
NKT cells from a representative individual. The percentages are averaged across two independent experiments (n = 5 subjects). (c) CD4+, DN and
CD8+ NKT cells (n = 10 000 per subset) were stimulated with the PBS57-hCD1d multimer. The amount of each cytokine released into the
supernatant was measured using cytokine bead array. Results are shown as the mean  one standard deviation from two independent
experiments (n = 3–5 subjects). *P < 0.05 (Kruskal–Wallis test with Steel–Dwass correction).
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these cells largely maintained their phenotype, suggesting
that further transition was either rare or dependent on
other stimuli, such as additional division cycles or a signal
that was not recapitulated in culture. In line with this
interpretation, distinct tissue-specific microenvironments
were shown previously to influence both the
differentiation34 and function35-37 of murine NKT cells.
CD4 NKT cells were either CD8 or CD8aa+ (none
expressed CD8b). Our data suggested that the expression of
CD8aa on CD4 NKT cells was reversible, potentially
reflecting the promiscuity of the a-chain promoter upon T-
cell stimulation. On this basis, it was conceivable that CD8+
NKT cells arose as a consequence of in vivo activation rather
than programmed differentiation, with functional differences
mirroring the chronology of antigen encounter on a cell-by-
cell basis. This notion was supported by the clonotypic
relationship between DN and CD8+ NKT cells. In comparison
with the CD4+ subsets, CD4 NKT cells displayed lower
clonogenic potential and greater functionality, particularly
with regard to the expression of cytolytic enzymes. These
features indicated a more differentiated phenotype,
substantiated by the relative absence of TRECs.
DN and CD8+ NKT cells were rarely terminally
differentiated in the classical sense, instead maintaining a
“central memory-like” phenotype in relation to
conventional T cells (CD27+CD28+CD127+). However, the
latter seldom expressed these molecules alongside CCR5.
This key difference potentially reflected contrasting selection
processes in the thymus and/or divergent programming at
the transcriptional level.13 In practical terms, the expression
of CCR5 indicated that differentiated NKT cells were poised
to mobilize rapidly and participate in early immune
responses triggered by the release of CC-chemokines.38
Collectively, these results provided evidence for a linear
differentiation pathway, as depicted in Figure 6. The most
likely alternative scenario was that CD4+ and CD4 NKT
cells arose separately as distinct lineages in the thymus.
However, this latter model failed to explain why CD4
NKT cells divided and differentiated in the periphery to a
much greater extent than CD4+ NKT cells. It was also
difficult to reconcile independent recombination events
with the contemporaneous occurrence and longitudinal
sharing of identical TCRb clonotypes between the CD4
and CD4+ subsets. Accordingly, our findings were most
consistent with a single lineage compartment and offered a
working hypothesis to clarify the peripheral ontogeny of
human NKT cells.
METHODS
Subjects
Adult blood samples were obtained from male and female
healthy volunteers aged 23–45 years, recruited via the Blood
Bank at the National Institutes of Health (Bethesda, MD).
Cord blood samples were obtained from healthy newborn
infants delivered full-term at the Shady Grove Hospital
Center (Gaithersburg, MD). The use of human samples for
this work was approved by the Institutional Review Board
of the National Institute of Allergy and Infectious Diseases
at the National Institutes of Health.
Culture medium, antibodies and dyes
PBMCs were isolated via standard density gradient
centrifugation and maintained in RPMI 1640 medium
supplemented with 10% fetal bovine serum, 2 mM
Table 2. Phenotypic comparison of T and NKT cell subsets.
Marker
T cells NKT cells
% of CD4+ % of CD8+ % of CD4+ % of CD8+ % of DN
NK-associated markers
CD56 1.1  1.2 7.8  6.1 42.1  16.3 75.4  18.2 79.1  12.7
CD161 8.9  5.0 9.9  4.8 62.1  25.4 88.7  10.6 92.1  8.2
NKB1 0.2  0.1 2.1  0.8 0.6  0.5 9.4  2.5 18.6  2.1
Differentiation-associated markers
CD11ahigh 38.4  6.4 40.6  12.0 78.0  13.9 96.3  2.4 93.6  4.9
CD62L 82.5  2.5 60.8  16.6 22.4  15.1 4.9  2.4 4.3  1.1
CD95 54.3  5.7 40.8  16.8 89.6  6.8 91.6  2.1 93.4  2.7
CD127 42.1  7.5 45.9  4.8 70.3  12.6 77.3  10.6 77.2  13.4
CCR5 9.1  4.2 28.1  13.1 63.3  20.1 85.2  17.2 90.0  12.1
Cytolytic enzymes
Granzyme A 3.7  1.3 41.4  14.5 56.1  21.2 95.1  9.7 96.8  2.3
Granzyme B 0.3  0.2 11.0  11.7 4.3  7.4 25.3  10.1 8.45  4.1
Percentages are given as mean  one standard deviation for 5–7 subjects.
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L-glutamine, 100 lg mL1 streptomycin and 100 U mL1
penicillin (all from Life Technologies, San Diego, CA, USA).
Freshly prepared cells for analysis in the absence of in vitro
stimulation were either used directly in flow cytometric
experiments or placed in culture overnight for concurrent
analysis with stimulated cells. All antibody reagents, either
purified or pre-conjugated, were obtained from BD
Biosciences (San Diego, CA, USA), except (1) anti-TRAV10
(Va24), anti-TRBV25 (Vb11) and anti-CD127 (Beckman
Coulter, Brea, CA, USA); (2) anti-granzyme B (Caltag,
Burlingame, CA, USA); and (iii) anti-CCR7 (R&D Systems,
Minneapolis, MN, USA). Multimeric complexes of PBS57-
hCD1d, a ligand analog of aGalCer-CD1d, were obtained
from the National Institutes of Health Tetramer Facility.
Flow cytometric analysis
Standard procedures were used to identify cell surface markers
and intracellular molecules. Processed samples were collected
using a modified LSRII flow cytometer (BD Biosciences)
configured as described previously.39 Data were analyzed with
FlowJo software version 8.1.1 (FlowJo, LLC, Ashland, OR, USA).
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Figure 3. Differentiation of NKT cells. (a) Expression of the indicated phenotypic markers is shown for CD4+ (top) and CD4 NKT cells (bottom)
from a representative individual. Quadrant numbers indicate percentage values. The percentages are averaged across four independent
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with the PBS57-hCD1d multimer (right panels) is shown for cord blood NKT (PBS57-hCD1d+) and conventional T cells (PBS57-hCD1d) from a
representative individual. The percentages are averaged across four independent experiments (n = 5 subjects). (c) TREC levels were quantified in
sort-purified NKT cell subsets. Horizontal bars indicate mean values. Each data point represents one individual. *P < 0.05 (Kruskal–Wallis test with
uncorrected pairwise comparisons for adult PBMCs). (d) Single CD4+, DN and CD8+ NKT cells were sorted and cloned. The fraction of cells that
expanded in vitro is shown as the mean  one standard deviation from three independent experiments (n = 3 or 4 subjects). ***P < 0.005
(Kruskal–Wallis test with Steel–Dwass correction).
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expressing a particular TRAV (a) or TRBV gene (c) is shown together with the fraction of each repertoire expressing a specific TCRa (b) or TCRb
sequence (d). The invariant TCRa sequence TRAV10/CVVSDRGSTLGRLY/TRAJ18 is shown in black.
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Clonal expansion of NKT cells
Single cells from CD4+, DN and CD8+ NKT cell subsets were
sorted into individual wells of a 96-well plate using a modified
FACSAria flow cytometer (BD Biosciences). Allogeneic PBMCs
from a healthy subject were loaded with aGalCer
(100 ng mL1; Enzo Life Sciences, Farmingdale, NY, USA)
and irradiated (4000 rad) for use as antigen-presenting cells.
The cultures were supplemented with IL-2 (100 U mL1) and
IL-7 (10 pg mL1) and replenished with fresh medium every
3 days. Active clones were transferred to 24-well plates after
9 days and harvested for phenotypic analysis by ﬂow
cytometry after further expansion.
Intracellular cytokine assay
PBMCs were suspended in culture medium with PBS57-hCD1d
(0.2 lg mL1), anti-CD28 (1 lg mL1) and anti-CD49d
(1 lg mL1) for 12 h at 37°C. Brefeldin A was added at a
concentration of 1 lg mL1 for the final 8 h. The cells were then
washed, stained for lineage/differentiation markers, washed again,
fixed/permeabilized using Cytofix/Cytoperm (BD Biosciences)
and stained for intracellular cytokines. After a final wash step, the
cells were fixed and stored at 4°C pending analysis.
Cytokine bead array
Cytokine production was assessed via cytometric bead array
using a Human Th1/Th2 Cytokine Kit (BD Biosciences).
Briefly, PBMCs were stained with the PBS57-hCD1d multimer
and directly conjugated antibodies to identify NKT cell
subsets, then sorted in bulk using a modified FACSAria flow
cytometer (BD Biosciences). Sorted cells were cultured in a
96-well plate at 10 000 cells/50 lL per well in the presence of
anti-CD28 (1 lg mL1) and anti-CD49d (1 lg mL1) with or
without PBS57-hCD1d (0.2 lg mL1) for 18 h at 37°C.
Supernatants were recovered after incubation and assessed for
cytokine production by flow cytometry using capture beads.
TREC analysis
TREC frequencies were evaluated via quantitative real-time
PCR (qRT-PCR) as described previously.24 Briefly, NKT cell
subsets were sorted in bulk as described above and lysed with
proteinase K. The solubilized DNA was then used directly as
the amplification template. qRT-PCR was performed in
duplicate tubes against a standard curve generated from serial
dilutions of TREC plasmid DNA.
Conventional TCR sequencing and data analysis
Viable NKT cells (1000–10 000 per subset) were sorted by
flow cytometry as described above to > 98% purity. Molecular
analysis of expressed TR gene rearrangements was then
performed using a template-switch anchored RT-PCR
according to reported protocols.40-42 A minimum of 50
functional sequences was analyzed for each sorted NKT cell
population. Each TCR sequence was aligned against all
reference TRAV and TRAJ or TRBV, TRBD and TRBJ gene
sequences from the IMGT database.43 The V genes were
aligned first, followed by the J genes and, for TRB sequences,
the D genes. The V and J genes were assigned as the longest,
highest percentage identity match with the TCR sequence.
Clonotype identity across subsets within individuals was
defined by precise matching of nucleotide sequences.
CD4+ CD4+ CD4 CD4
CCR5 CCR5+ CD8 CD8+
CD4+ CCR5 (212) 
CD4+ CCR5+ 9 (102) 
CD4 CD8 1 5 (414) 
CD4 CD8+ 1 4 33 (344) 
Time: 6 months 
CD4+ CD4+ CD4 CD4
CCR5 CCR5+ CD8 CD8+
CD4+ CCR5 5 5 0 0 
CD4+ CCR5+ 0 9 3 2 
CD4 CD8 2 5 28 11 
CD4 CD8+ 0 1 18 26 Ti
m
e:
 0
 m
on
th
s 
(b)
(a)
Figure 5. High-throughput analysis of TCR use in NKT cell subsets.
CD4+CCR5, CD4+CCR5+, DN and CD8+ NKT cells were sort-
purified from healthy subjects (n = 3). A high-throughput
sequencing approach was used to profile the corresponding TCRb
repertoires. The experiment was repeated 6 months later. (a) The
number of unique TCRb sequences identified for each NKT cell
subset is listed in parentheses. Numbers below the diagonal indicate
how many of these unique TCRb sequences were shared across NKT
cell subsets from the same individual at a single time point. (b) The
number of shared unique TCRb sequences is shown for each
combination of NKT cell subsets within an individual at the indicated
time points.
CD4+ 
CCR5
CD4+ 
CCR5+
CD4  
CD8
CD4
CD8 +
TREC
CCR5
CD161
Grz A/B
Proliferative 
Capacity
NKT
?
CD56
Figure 6. The peripheral ontogeny of human NKT cells. Based on the
phenotypic, functional and molecular data presented in this study, we
propose a linear differentiation model that describes the peripheral
ontogeny of human NKT cells. The depicted lineage relationships are
consistent with previous reports, as reviewed in detail elsewhere.13
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High-throughput TCR sequencing and data analysis
Libraries were constructed as described previously.44 Briefly,
mRNA was extracted from sorted cells using a lMACS mRNA
Isolation Kit (Miltenyi Biotec, Sunnyvale, CA, USA). A template-
switch anchored RT-PCR was then performed using a modified
version of the SMARTer RACE cDNA Amplification Kit
(Clontech, Mountain View, CA, USA). After cDNA synthesis and
purification, TCRb templates were amplified using a KAPA Real
Time Library Amplification Kit (Kapa Biosystems, Wilmington,
MA, USA), with a TRBC gene-specific 30 primer (50-
GCTTCTGATGGCTCAAACACAGCGACCT-30) and a standard
50 primer (5 Primer II A; Clontech). Amplified samples were
separated using an E-Gel Size Select 2% Gel System (Life
Technologies). Illumina adaptors were added via a second PCR
using the KAPA Real Time Library Amplification Kit (Kapa
Biosystems), incorporating 20 lL of each library with one 30
primer (50-CAAGCAGAAGACGGCATACGAGATTGCTTCTG
ATGGCTCAAACACAGCGACCT-30) and two 50 primers (PE1
FCB ILL 1_2 and the corresponding PE1 ILL barcode 2_2
primer). PCR products were cleaned using an AMPure XP Kit
(Beckman Coulter). Libraries were quantified using a KAPA
Library Quantification Kit Illumina (Kapa Biosystems) and
clustered in the Illumina Cbot according to the manufacturer’s
instructions (Illumina, San Diego, CA, USA). Sequencing was
performed using an Illumina HiSeq instrument with a modified
protocol for 150 base paired-end reads.44 Read 1 was sequenced
with the Illumina read 1 primer. Read 2 was sequenced with a
mix of 13 TRBJ gene-specific primers. The minimum coverage
for each sampled population was approximately 10 reads per
input cell. TCRb annotation was performed by combining a
custom Java script with the BLAST1 program (National Center
for Biotechnology Information, National Institutes of Health).
Briefly, the V and J genes were identified first, and the CDR3b
was determined by finding the conserved cysteine at the 50 end
and the conserved phenylalanine at 30 end. Unique TCRb
combinations (V-D-J) were collapsed to determine the count.
Statistical analysis
Significance testing was implemented using JMP software
version 14 (SAS Institute Inc., Cary, NC, USA).
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